-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NPC-21 in Cytomegalovirus (HHV-5) Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.NPC-21 in Cytomegalovirus (HHV-5) InfectionsDrug Details:NPC-21 is under development for the treatment of cytomegalovirus infection in...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BGBA-445 in Nasopharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BGBA-445 in Nasopharyngeal Cancer Drug Details: BGBA-445 is under development for the treatment of advanced,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BGBA-445 in Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BGBA-445 in Melanoma Drug Details: BGBA-445 is under development for the treatment of advanced, metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BGBA-445 in Bladder Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BGBA-445 in Bladder Cancer Drug Details: BGBA-445 is under development for the treatment of advanced,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BGBA-445 in Renal Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BGBA-445 in Renal Cell Carcinoma Drug Details: BGBA-445 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BGBA-445 in Metastatic Transitional (Urothelial) Tract Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BGBA-445 in Metastatic Transitional (Urothelial) Tract Cancer Drug Details: BGBA-445 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BGBA-445 in Squamous Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BGBA-445 in Squamous Non-Small Cell Lung Cancer Drug Details: BGBA-445 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EMB-09 in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EMB-09 in Gastric Cancer Drug Details: EMB-09 is under development for the treatment of locally...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EMB-09 in Metastatic Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EMB-09 in Metastatic Melanoma Drug Details: EMB-09 is under development for the treatment of locally...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EMB-09 in Endometrial Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EMB-09 in Endometrial Cancer Drug Details: EMB-09 is under development for the treatment of locally...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.